Navigation Links
Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
Date:6/12/2008

rofile observed for belimumab suggest that it has the potential to play an important role in the treatment of SLE."

SLE is a chronic, life-threatening autoimmune disease. It is estimated that approximately 1.5 million people in the United States and approximately 5 million worldwide suffer from various forms of lupus, including SLE.

"At Week 52 in belimumab patients with serologically active SLE, we saw significant reductions in SLE disease activity versus placebo based on multiple measures of clinical effect, including the response rate chosen as the primary efficacy endpoint of the Phase 3 trials," said William W. Freimuth, M.D., Ph.D., Vice President, Clinical Research - Immunology, Rheumatology and Infectious Diseases. "We are encouraged by the continued improvement in these patients through three years. Belimumab could represent a significant advance in the treatment of SLE if Phase 2 results are confirmed in the Phase 3 trials that are currently ongoing."

LymphoStat-B (belimumab) is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in August 2006. The first Phase 3 data for LymphoStat-B are expected by mid- 2009, and all Phase 3 data to support regulatory filings are expected in fall 2009.

Key Findings from the Phase 2 Study Continuation Through Three Years

The data presented today at EULAR 2008 demonstrate that continued treatment with belimumab is associated with sustained improvement or stabilization of SLE disease activity in serologically active patients through three years of treatment. Belimumab decreased the frequency of SLE disease flares and reduced the need for high-dose steroids in these patients over time. The overall incidence of adverse events (in general and by system organ class), serious adverse events, infections, malignancies and laboratory abnormalities continued to decrease or stabilize from Week 52 to Week 160.

The evidence of sus
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
2. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
3. Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
4. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
5. St. Jude Finds Dancing Hair Cells Are Key to Humans Acute Hearing
6. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
7. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
8. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
9. First Human Implant of New Archus Orthopedics Facet Replacement System
10. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
11. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014   Acutus Medical, Inc. (ACM), ... 3D Cardiac Chamber Imaging and Dipole Density Mapping system ... sustain complex cardiac arrhythmias, including atrial fibrillation, announced it ... its imaging/mapping system as well as bring to market ... Medical to complete work on the AcQMap TM ...
(Date:9/30/2014)... PAUL, Minn. , Sept. 30, 2014 ... the United States abused prescription pain relievers ... include detoxification or maintenance treatment, which entails the use ... costs of these treatments are important when developing and ... by pharmacy benefit manager Prime Therapeutics LLC ...
(Date:9/30/2014)... Calif. , Sept. 30, 2014  Life ... group focused on supporting promising emerging biotech, medical ... been named the Top Angel Investment Group in ... as the best performer out of 370 angel ... historical performance, network strength (connections), selection aptitude and ...
Breaking Medicine Technology:Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3
... FORT WASHINGTON, Pa., Nov. 13 ReSearch Pharmaceutical Services, ... integrated clinical development outsourcing solutions to the bio-pharmaceutical industry, ... quarter and nine months ended September 30, 2009. ... the quarter and nine months ended September 30, 2008. ...
... Calif., Nov. 13 Walt Maclay, President of ... been selected to speak on "Data Acquisition for ... 9, 2009. BIOMEDevice ( http://www.devicelink.com/expo/biomed09/index.html ) ... leaders in medical devices. The show offers a ...
Cached Medicine Technology:ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 2ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 3ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 4ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 5ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 6ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 7ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 8ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 9ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 10ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 11Voler Systems President Speaks at BIOMEDevice San Jose 2Voler Systems President Speaks at BIOMEDevice San Jose 3
(Date:10/1/2014)... Chicago IL (PRWEB) October 01, 2014 ... it has launched a new Other-Sonic Ultrasound ... public with information about the litigation surrounding the ... William Beaumont Hospital in Royal Oak, Michigan, which ... gel. The Firm is representing William Beaumont patients ...
(Date:10/1/2014)... Indosoft, Inc., a leading provider of scalable Asterisk-based ... added support for Sangoma Lyra Answering Machine Detection ... a history of bringing innovative products to market in the ... benefit to those using Asterisk as a platform for their ... of Q-Suite. , In the past decades, outbound call centers ...
(Date:10/1/2014)... 2014 The annual Social Security cost-of-living adjustment ... says a new forecast by The Senior Citizens League ... index (CPI) data through August, TSCL forecasts that COLAs will ... sixth consecutive year of record low COLAs,” states TSCL Chairman, ... automatic in 1975,” he notes. , Over the past five ...
(Date:10/1/2014)... October 01, 2014 QueenBeeTickets.com is giving music ... the singer’s upcoming North American tour, which has him traveling ... come. , Click here to view the selection ... performer’s newest album, is due to come out on October ... shortly thereafter. Bob Seger concert tickets are available for shows ...
(Date:9/30/2014)... same time could stop them from becoming resistant to ... Research * today (Wednesday). , The researchers, ... MedImmune, the global biologics research and development arm of ... two treatments helped the immune system hunt down and ... radiotherapy in mice with breast, skin and bowel cancers. ...
Breaking Medicine News(10 mins):Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 2Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 3Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 4Health News:Indosoft Announces Q-Suite Support For Sangoma Lyra 2Health News:The Senior Citizens League (TSCL) Says Sixth Consecutive Year Of Record Low COLAs “Unprecedented” 2Health News:The Senior Citizens League (TSCL) Says Sixth Consecutive Year Of Record Low COLAs “Unprecedented” 3Health News:Bob Seger Presale Tickets: QueenBeeTickets.com Delights Fans with Discounted Tickets for All 20 Stops on Seger’s “Ride Out” Tour with The Silver Bullet Band 2Health News:Immunotherapy could stop resistance to radiotherapy 2
... Kaiser ... medical surge facility at the 2010 Pasadena Marathon in California. , ... Pasadena, CA (Vocus) March 17, 2010 -- Kaiser ... DRASH medical surge facility at the 2010 Pasadena Marathon in California., , , ...
... million more Americans access to health insurance , ... year of fierce partisan debate, the Democrat-controlled House ... $940 billion health-care reform bill, which would extend ... prevent insurance companies from denying coverage to people ...
... the genomes of thousands of "never smokers" diagnosed with lung cancer ... say could be responsible for a significant number of those cancers. ... Lancet Oncology , the researchers reported that about 30 percent ... the same uncommon variant, or allele, residing in a gene known ...
... organization Eagle Forum, made the following remarks after the public announcement that formerly pro-life Democrat Bart Stupak (D-MI) will cast a "yes" vote for the Senate ... ... ... ...
... more Americans access to health insurance , FRIDAY, March ... furiously debated $940 billion health-care reform bill moving toward ... boils down to one simple tenet: More Americans should ... is the coverage of 31 million uninsured individuals, and ...
... 21 Family Research Council President Tony Perkins released the following statement in response to reports that President Obama may issue an executive order regarding government funding of ... ... ... ...
Cached Medicine News:Health News:DRASH Keeps Marathon Runners On Track 2Health News:DRASH Keeps Marathon Runners On Track 3Health News:House Democrats Approve Health-Care Reform Bill 2Health News:House Democrats Approve Health-Care Reform Bill 3Health News:House Democrats Approve Health-Care Reform Bill 4Health News:Gene is linked to lung cancer development in never-smokers 2Health News:Gene is linked to lung cancer development in never-smokers 3Health News:Gene is linked to lung cancer development in never-smokers 4Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 2Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 3Health News:Showdown Over Health-Care Reform Bill Nears 2Health News:Showdown Over Health-Care Reform Bill Nears 3Health News:Showdown Over Health-Care Reform Bill Nears 4Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 2Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 3Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 4
... in two tip styles- the ... staggered eyes, and the angled ... catheter valve options, SAFE-T-VAC and ... with virtually no residual vacuum ...
Sterile Single Loop Pediatric Suction Catheters with TOUCH-TROL Valve...
... Our Tri-Flo® suction catheter design ... to your patients while still providing ... pediatric catheters (5/6, 8 or 10 ... facilitate proper catheter placement. Our complete ...
Suction catheter with thumb valve, two eyes, whistle tip...
Medicine Products: